miR-22-3p 通过抑制 AMPK/SIRT1/PGC-1α 通路调节肌纤维类型转换。
miR-22-3p regulates muscle fiber-type conversion through inhibiting AMPK/SIRT1/PGC-1α pathway.
机构信息
Key Laboratory for Animal Disease-Resistance Nutrition of China Ministry of Education, Institute of Animal Nutrition, Sichuan Agricultural University, Chengdu, Sichuan, P. R. China.
College of Food Science, Sichuan Agricultural University, Yaan, Sichuan, P. R. China.
出版信息
Anim Biotechnol. 2021 Apr;32(2):254-261. doi: 10.1080/10495398.2020.1763375. Epub 2020 May 14.
MicroRNAs (miRNAs) are a class of conserved non-coding RNAs that are widely regarded as important regulators in a variety of biological processes. Increasing evidence has revealed that skeletal muscle fiber-type conversion is regulated by miRNAs, but the molecular mechanism is still not fully understood. In this study, we confirmed the role of miR-22-3p on skeletal muscle fiber-type conversion and investigated its potential mechanism in C2C12 myotubes. Here, we found that the miR-22-3p mimics inhibited the expressions of myosin heavy chain I (MyHC I), MyHC IIa and promoted the expression of MyHC IIb, while miR-22-3p inhibitor got inverse results. miR-22-3p mimics also downregulated phosphorylated AMPK, SIRT1 and PGC-1ɑ protein levels, which control the expression of oxidative fiber-related genes. Furthermore, Compound C (AMPK inhibitor) eliminated the effect of miR-22-3p inhibitor on MyHC I, MyHC IIa and MyHC IIb expressions. However, AICAR (AMPK activator) also abolished the effect of miR-22-3p mimics on MyHC I, MyHC IIa and MyHC IIb expressions. Collectively, our results suggest that miR-22-3p regulates skeletal muscle fiber-type conversion through inhibiting AMPK/SIRT1/PGC-1ɑ signaling pathway.
微小 RNA(miRNAs)是一类保守的非编码 RNA,被广泛认为是多种生物过程中的重要调节因子。越来越多的证据表明,miRNAs 调节骨骼肌纤维类型转换,但分子机制尚不完全清楚。在本研究中,我们证实了 miR-22-3p 在骨骼肌纤维类型转换中的作用,并研究了其在 C2C12 肌管中的潜在机制。在这里,我们发现 miR-22-3p 模拟物抑制肌球蛋白重链 I(MyHC I)、MyHC IIa 的表达,促进 MyHC IIb 的表达,而 miR-22-3p 抑制剂则得到相反的结果。miR-22-3p 模拟物还下调磷酸化 AMPK、SIRT1 和 PGC-1ɑ 蛋白水平,这些蛋白控制氧化纤维相关基因的表达。此外,Compound C(AMPK 抑制剂)消除了 miR-22-3p 抑制剂对 MyHC I、MyHC IIa 和 MyHC IIb 表达的影响。然而,AICAR(AMPK 激活剂)也消除了 miR-22-3p 模拟物对 MyHC I、MyHC IIa 和 MyHC IIb 表达的影响。总之,我们的结果表明,miR-22-3p 通过抑制 AMPK/SIRT1/PGC-1ɑ 信号通路调节骨骼肌纤维类型转换。